PMFA
GMAB icon

Plante Moran Financial Advisors’s Genmab GMAB Stock Holding History

Plante Moran Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769 Buy
+28
New +$744 ﹤0.01% 979
2022
Q3 		– Sell
-151
Closed -$5K – 931
2022
Q2 		$5K Buy
+151
New +$4.89K ﹤0.01% 711
2021
Q3 		– Sell
-100
Closed -$4K – 958
2021
Q2 		$4K Hold
100
– – ﹤0.01% 817
2021
Q1 		$3K Hold
100
– – ﹤0.01% 860
2020
Q4 		$4K Buy
+100
New +$3.74K ﹤0.01% 716

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Plante Moran Financial Advisors's GMAB Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Genmab (GMAB) in Q2 2026: 28 shares worth $769. The stake represents ﹤0.01% of the portfolio and ranks #979 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in GMAB as recently as Q2 2022.

Plante Moran Financial Advisors first reported a position in GMAB in Q4 2020 and has held it in 5 quarters since. The position peaked at $5K in Q2 2022. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Plante Moran Financial Advisors held 28 shares of Genmab worth $769 as of Q2 2026.
  • Genmab was a new Plante Moran Financial Advisors position in Q2 2026.
  • Genmab made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #979 holding.
  • Plante Moran Financial Advisors first reported a position in Genmab in Q4 2020 and has held it in 5 quarters since.
  • Plante Moran Financial Advisors's Genmab position peaked at $5K in Q2 2022.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.